Search results for "United States"

showing 10 items of 383 documents

Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?

2016

Objectives To better understand the influence of prostate-specific antigen (PSA) screening and other health system determinants on prognosis of prostate cancer, up-to-date relative survival (RS), stage distributions, and trends in survival and incidence in Germany were evaluated and compared with the United States of America (USA). Patients and methods Incidence and mortality rates for Germany and the USA for the period 1999-2010 were obtained from the Centre for Cancer Registry Data at the Robert Koch Institute and the USA Surveillance Epidemiology and End Results (SEER) database. For analyses on stage and survival, data from 12 population-based cancer registries in Germany and from the SE…

OncologyAdultMalemedicine.medical_specialtyAdolescentUrologyPopulation03 medical and health sciencesProstate cancerYoung Adult0302 clinical medicineAge DistributionPredictive Value of TestsResidence CharacteristicsInternal medicineGermanymedicineSurveillance Epidemiology and End ResultsHumansMass Screening030212 general & internal medicineeducationMass screeningAgedNeoplasm Stagingeducation.field_of_studyRelative survivalbusiness.industryMortality rateIncidence (epidemiology)IncidenceProstatic NeoplasmsReproducibility of ResultsMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisUnited StatesCancer registry030220 oncology & carcinogenesisbusinessDemographySEER ProgramBJU international
researchProduct

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fet…

2015

The lifetime utility of liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) is still controversial. The aim of this study was to ascertain when LT is cost-effective for HCC patients, with a view to proposing new transplant selection criteria. The study involved a real cohort of potentially transplantable Italian HCC patients (n = 2419 selected from the Italian Liver Cancer group database) who received nontransplant therapies. A non-LT survival analysis was conducted, the direct costs of therapies were calculated, and a Markov model was used to compute the cost utility of LT over non-LT therapies in Italian and US cost scenarios. Post-LT survival was calculated using t…

OncologyMaleTime FactorsDatabases Factualmedicine.medical_treatmentCost-Benefit AnalysisLiver transplantationClinical endpointLiver NeoplasmsSurgery; Transplantation; HepatologyHealth Care Costshepatocellular carcinomaMiddle AgedMarkov ChainsTumor BurdenModels EconomicTreatment OutcomeItalyHepatocellular carcinomaFemaleQuality-Adjusted Life Yearsalpha-FetoproteinsAlpha-fetoproteinMonte Carlo Methodmedicine.medical_specialtyCarcinoma HepatocellularSettore MED/12 - GASTROENTEROLOGIADecision Support Techniquesalpha-fetoproteinPredictive Value of TestsInternal medicinemedicineHumansneoplasmsSurvival analysisAgedProportional Hazards ModelsRetrospective StudiesTransplantationHepatologyProportional hazards modelbusiness.industryPatient SelectionRetrospective cohort studymedicine.diseaseSurvival Analysisdigestive system diseasesUnited StatesSurgeryLiver TransplantationTransplantationMultivariate AnalysisSurgerybusiness
researchProduct

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of r…

2015

BackgroundAcquired resistance to BRAF inhibitors (BRAFi) is a near-universal phenomenon caused by numerous genetic and non-genetic alterations. In this study, we evaluated the spectrum, onset, pattern of progression, and subsequent clinical outcomes associated with specific mechanisms of resistance.MethodsWe compiled clinical and genetic data from 100 patients with 132 tissue samples obtained at progression on BRAFi therapy from 3 large, previously published studies of BRAFi resistance. These samples were subjected to whole-exome sequencing and/or polymerase chain reaction-based genetic testing.ResultsAmong 132 samples, putative resistance mechanisms were identified in 58%, including NRAS o…

OncologyNeuroblastoma RAS viral oncogene homologMaleCancer ResearchSkin NeoplasmsTime FactorsResistanceDNA Mutational AnalysisDrug ResistanceMedizinKaplan-Meier EstimateBioinformaticsmedicine.disease_causeRisk Factors2.1 Biological and endogenous factorsAetiologyVemurafenibMelanomaCancerMutationTumorDabrafenibMelanomaAcquiredMiddle AgedPhenotypeEuropePhenotypeTreatment OutcomeSpliceOncologyMeta-analysisPublic Health and Health ServicesDisease ProgressionFemalemedicine.drugSignal TransductionProto-Oncogene Proteins B-rafmedicine.medical_specialtyOncology and CarcinogenesisNRASAntineoplastic AgentsBiologyDisease-Free SurvivalArticleBRAFMEK1Clinical ResearchInternal medicineGeneticsmedicineBiomarkers TumorHumansGenetic Predisposition to DiseaseOncology & CarcinogenesisProtein Kinase InhibitorsProportional Hazards ModelsProportional hazards modelAustraliaDabrafenibmedicine.diseaseMAPKUnited StatesMeta-analysisVemurafenibDrug Resistance NeoplasmMutationNeoplasmBiomarkersEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Role of Immunotherapy in the Management of Hepatocellular Carcinoma: Current Standards and Future Directions

2020

The multikinase inhibitor sorafenib was the only approved systemic therapy in advanced hepatocellular carcinoma (HCC) for about a decade. In recent years, the number of approved agents has increased significantly as a result of a number of positive phase iii clinical trials. Lenvatinib as a first-line treatment, and regorafenib, cabozantinib, and ramucirumab in the second-line setting are now approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency. In phase II studies, immunotherapy with nivolumab and monotherapy using pembrolizumab yielded impressive results for overall survival in therapy-naïve and pretreated patients, leading to the accelerated approval …

OncologySorafenibmedicine.medical_specialtyCarcinoma HepatocellularCabozantinibHepatocellular carcinomadurvalumabIpilimumabReview ArticlePembrolizumabRamucirumab03 medical and health scienceschemistry.chemical_compoundtremelimumab0302 clinical medicineRegorafenibInternal medicinemedicineHumans030212 general & internal medicineipilimumabClinical Trials as Topicbusiness.industryLiver NeoplasmsSorafenibdigestive system diseasesUnited StatesNivolumabchemistry030220 oncology & carcinogenesispembrolizumabImmunotherapyNivolumabLenvatinibbusinesscheckpoint inhibitorsmedicine.drugCurrent Oncology
researchProduct

Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community‐Based Cohorts: A Meta‐Analysis

2017

Background Microvascular dysfunction is a marker of early vascular disease that predicts cardiovascular events. Whether metabolically healthy obese individuals have impaired microvascular function remains unclear. The aim of this study was to evaluate the relation of obesity phenotypes stratified by metabolic status to microvascular function. Methods and Results We meta‐analyzed aggregate data from 3 large cohorts (Brazilian Longitudinal Study of Adult Health, the Framingham Heart Study, and the Gutenberg Heart Study; n=16 830 participants, age range 19–90, 51.3% men). Regression slopes between cardiovascular risk factors and microvascular function, measured by peripheral arterial tonometr…

Oncologycardiovascular risk factorsMaleEpidemiology030204 cardiovascular system & hematologyOverweightCohort Studies0302 clinical medicineendothelial functionRisk FactorsGermanyVascular Disease030212 general & internal medicine2. Zero hungerSystematic Review and Meta‐AnalysisMiddle Aged3. Good healthMeta-analysisPulsatile FlowEndothelium/Vascular Type/Nitric OxideFemalemedicine.symptomCardiology and Cardiovascular MedicineBrazilCohort studyAdultmedicine.medical_specialtyManometrybody mass indexmetabolic syndromeFingers03 medical and health sciencesInternal medicinemedicineHumansObesityAgedObesity Metabolically BenignVascular diseasebusiness.industryCase-control studyOverweightmedicine.diseaseObesityUnited StatesEndocrinologyCase-Control StudiesMicrovesselsEndothelium VascularMetabolic syndromebusinessBody mass indexJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
researchProduct

A return to humane medicine: Osler's legacy.

2017

Sir William Osler is celebrated today not only for his contributions to the advancement of medical education, but also for the humanism he brought to the practice of medicine. He was a doctor whose bedside skills and manners were emulated, and can legitimately be called an infectious diseases specialist. Nonetheless, he was also a humanist in the broader sense of the term, a student of human affairs and human nature, who emphasised compassion for the individual. To what extent, if any, are today's challenges influenced by departures from the paradigms created by Osler? In this paper we sought to ascertain whether such a tradition is still relevant to current practice and may foster a new pe…

OntarioInfectious Disease MedicinePhysician-Patient RelationsEducation MedicalHumanities Formazione medica Relazione medico-paziente Osler Empatia Medicina Interna Malattie infettiveAttitude of Health PersonnelHistory 19th CenturyHistory 20th CenturySettore MED/43 - MEDICINA LEGALEHumane Medicine Humanities Medical Education Patient-physician relationship Osler Empathy Internal Medicine Infectious diseasesUnited StatesSettore MED/02 - STORIA DELLA MEDICINAPhysiciansHumanismInternal MedicineOsler's legacyHumansHistory of MedicinePractice Patterns Physicians'Medicina umanaMedical Humanities
researchProduct

Crossing Borders: An Online Interdisciplinary Course in Health Informatics for Students From Two Countries.

2017

A cross-countries and interprofessional novel approach for delivering an international interdisciplinary graduate health informatics course online is presented. Included in this discussion are the challenges, lessons learned, and pedagogical recommendations from the experiences of teaching the course. Four professors from three different fields and from three universities collaborated in offering an international health informatics course for an interdisciplinary group of 18 US and seven Norwegian students. Highly motivated students and professors, an online technology infrastructure that supported asynchronously communication and course delivery, the ability to adapt the curriculum to meet…

Organizational Behavior and Human Resource ManagementNursing (miscellaneous)020205 medical informaticsUniversitiesStrategy and ManagementPharmaceutical ScienceHealth Informatics02 engineering and technologyHealth informaticsInformation scienceCourse (navigation)Drug DiscoveryComputingMilieux_COMPUTERSANDEDUCATION0202 electrical engineering electronic engineering information engineeringHumansCooperative BehaviorStudentsCurriculumSimulationMarketingPharmacologyMedical educationInternetbusiness.industryNorway05 social sciences050301 educationInternational healthUnited StatesInformaticsThe InternetInterdisciplinary CommunicationCurriculumbusiness0503 educationMedical InformaticsContent managementComputers, informatics, nursing : CIN
researchProduct

Comment on “Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States.”

2021

PKlcsh:RC633-647.5business.industry10031 Clinic for Angiology2720 HematologyPK DEFICIENCYDistribution (economics)610 Medicine & healthPK deficiency2725 Infectious Diseaseslcsh:Diseases of the blood and blood-forming organsHematologyUnited StatesWest African CountriesWest africanInfectious Diseases10032 Clinic for Oncology and HematologyDeficiencyMedicinebusinessSocioeconomicsLetter to the EditorMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Collective defence portfolios of ant hosts shift with social parasite pressure

2014

Host defences become increasingly costly as parasites breach successive lines of defence. Because selection favours hosts that successfully resist parasitism at the lowest possible cost, escalating coevolutionary arms races are likely to drive host defence portfolios towards ever more expensive strategies. We investigated the interplay between host defence portfolios and social parasite pressure by comparing 17 populations of two Temnothorax ant species. When successful, collective aggression not only prevents parasitation but also spares host colonies the cost of searching for and moving to a new nest site. However, once parasites breach the host's nest defence, host colonies should resor…

ParasitismGeneral Biochemistry Genetics and Molecular BiologyHost-Parasite InteractionsNestmedicineAnimalsParasite hostingSocial BehaviorResearch ArticlesGeneral Environmental ScienceBrood parasiteGeneral Immunology and MicrobiologyTemnothoraxbiologyAntsHost (biology)AggressionEcologyQuebecGeneral MedicineAnt colonybiology.organism_classificationUnited StatesAggressionmedicine.symptomGeneral Agricultural and Biological SciencesProceedings of the Royal Society B: Biological Sciences
researchProduct

An Appeal for Implementing Social Assistance and Welfare Programs for European Children Challenged by Parental Loss

2018

The authors of this commentary, many of whom are part of a working group on social pediatrics supported by some of the European national pediatric societies member of EPA-UNEPSA, conclude that more studies are needed to cross the boundaries between disciplines, for example, looking at the inter-relationship of family life and child health and how parental loss is affecting the micro and macro level of child healthcare service systems. Therefore, this article aims to alert pediatricians to the impact of parental loss on child health and wellbeing. It emphasizes the importance of implementing preventive and social support programs for achieving health promotion and health-protective effects.

ParentsEconomic growthbusiness.industrymedia_common.quotation_subjectAppealAid to Families with Dependent ChildrenUnited StatesChild healthEuropeSocial assistanceparental loss social assistance welfare child healthPediatrics Perinatology and Child HealthHumansMedicineChildbusinessWelfareSocial WelfareProgram EvaluationState Governmentmedia_commonThe Journal of Pediatrics
researchProduct